PathAI
Contact SalesAI-powered pathology for accurate diagnosis and drug development
By Tanmay Verma, Founder · Last verified 26 May 2026
3.5k views
Added 4/3/2026
80/100Safe BetAI-powered pathology for accurate diagnosis and drug development
By Tanmay Verma, Founder · Last verified 26 May 2026
Affiliate disclosure: We earn a commission when you use our links. Editorial picks are independent. How we choose.
PathAI is a top choice for biopharma and large clinical labs needing validated, scalable AI in pathology. Its regulatory-grade algorithms and biomarker quantification are strengths. However, lack of public pricing and self-service options limit accessibility. For smaller labs, consider open-source alternatives like QuPath.
Compare with: PathAI vs Tempus, PathAI vs Viz.ai, PathAI vs Regard
Last verified: May 2026
PathAI stands out for its regulatory-grade algorithms specifically designed for pathology workflows, supporting FDA submissions and clinical trial endpoints. The platform's AI-assisted tissue analysis and quantitative biomarker scoring are well-suited for large-scale studies. A notable limitation is the absence of transparent pricing and self-service signup, which may deter smaller labs. Integration with existing lab information systems is a plus, but the tool requires digitized slides. PathAI is ideal for biopharma companies running clinical trials and large diagnostic labs seeking standardized AI-assistance. For smaller labs with limited budgets, open-source tools like QuPath or path64 may be more practical.
Skip PathAI if Skip PathAI if you are a small pathology lab with limited budget or need an open-source, self-hosted AI tool.
How likely is PathAI to still be operational in 12 months? Based on 6 signals including funding, development activity, and platform risk.
PathAI delivers AI-powered pathology solutions to improve diagnostic accuracy and accelerate drug development. Built for pathologists, biopharma companies, and clinical researchers, the platform leverages deep learning to analyze tissue samples with high precision. Key features include AI-assisted tissue analysis for cancer detection, automated workflow integration with existing lab systems, and quantitative biomarkers for clinical trials. PathAI's models are trained on diverse, global datasets to ensure robust performance. Unlike general-purpose image analysis tools, PathAI is purpose-built for pathology, offering regulatory-grade algorithms that support FDA submissions and translational research.
Tell us what you want to build — we'll match the AI tools that fit your goal, budget & existing stack.
Concrete scenarios for the personas PathAI actually fits — and what changes day-one when you adopt it.
Running a late-stage clinical trial requiring consistent biomarker quantification across thousands of slides.
Outcome: Deploy PathAI's quantitative biomarker assays to standardize scoring, reduce inter-reader variability, and deliver regulatory-ready endpoint data.
Reviewing daily cancer biopsies and need AI-assisted triage to prioritize suspicious cases.
Outcome: Integrate PathAI's AI-assisted tissue analysis with the existing LIS to flag high-risk biopsies, improving diagnostic throughput and accuracy.
Enterprise pricing may be prohibitive for small labs; requires digitized slides for full benefit; not available for direct purchase online.
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
For each published PathAI tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.
Clinical
Custom
Ideal for
Large clinical labs and hospital networks requiring AI-assisted diagnosis and quality assurance.
What this tier adds
Custom enterprise pricing; includes AI-assisted diagnosis, biomarker quantification, and quality assurance features.
Biopharma
Custom
Ideal for
Biopharma companies conducting clinical trials and companion diagnostics development.
What this tier adds
Custom enterprise pricing; tailored for clinical trial pathology, companion diagnostics, and endpoint analysis.
The company stage and team size where PathAI's pricing actually pencils out — and where peers do it cheaper.
PathAI offers custom enterprise pricing, typically fitting large clinical labs and biopharma companies with substantial budgets. For smaller organizations, the cost may be prohibitive compared to open-source alternatives like QuPath.
How long it actually takes to get something useful out of PathAI — broken out by persona, not the marketing-page minute.
Setup time varies by deployment: for cloud-based integration with an existing LIS, plan for 2–4 weeks of validation and workflow configuration. Biopharma studies may require additional time for assay customisation and regulatory documentation.
Common stack mates teams adopt alongside PathAI, with the specific reason each pairing earns its keep.
Used PathAI? Help shape our editorial sentiment research.
© 2026 RightAIChoice. All rights reserved.
Built for the AI community.
Last calculated: May 2026
AI-powered relationship intelligence platform for sales teams